Skip to content
S12 E02: Rethinking multiple sclerosis care: Challenging old frameworks episode artwork

Mar 24, 2026 6 min

S12 E02: Rethinking multiple sclerosis care: Challenging old frameworks

from EMJ GOLD: Pharma news, views and analysis Hosted by EMJ

In Part 2, Hideki Garren, Roche, discusses the challenge of measuring MS progression and the importance of better data, imaging and patient insight. Guest bio Hideki Garren is Senior Vice President and Global Head of Clinical Development, Neurology, Roche, appointed in September 2024. He brings extensive leadership experience across biotech and pharma, including senior roles at Roche, where he led global neuroimmunology development. Prior to this, Hideki served as Chief Medical Officer at Prothena Biosciences and held board and leadership roles at Coya Therapeutics, Novartis, and Bayhill Therapeutics, which he co-founded. He completed his neurology residency and postdoctoral fellowship at Stanford University, where he also served as an adjunct clinical professor. Hideki holds a bachelor's degree from Caltech and an MD and PhD from UCLA.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

S12 E02: Rethinking multiple sclerosis care: Challenging old frameworks

0:00 6:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of EMJ GOLD: Pharma news, views and analysis?

This episode is 6 minutes long.

When was this EMJ GOLD: Pharma news, views and analysis episode published?

This episode was published on March 24, 2026.

Can I download this EMJ GOLD: Pharma news, views and analysis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.